Total Marrow Irradiation for Refractory Acute Leukemia

NCT00686556 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Acute Lymphoblastic Leukemia
Myelodysplastic Syndrome
Multiple Myeloma

Interventions

DRUG: cyclophosphamide
DRUG: cyclosporine
DRUG: Fludarabine
DRUG: mycophenolate mofetil
RADIATION: total marrow irradiation
PROCEDURE: umbilical cord blood transplantation
BIOLOGICAL: Granulocyte colony-stimulating factor
BIOLOGICAL: HLA-matched related donor bone marrow

Sponsor

Masonic Cancer Center, University of Minnesota